--- title: "Zenas BioPharma Insider Bought Shares Worth $1,012,800, According to a Recent SEC Filing" type: "News" locale: "en" url: "https://longbridge.com/en/news/286872009.md" description: "Leon O Moulder Jr, CEO of Zenas BioPharma, purchased 60,000 shares for $1,012,800 on May 18, 2026. Following this transaction, he controls a total of 2,306,122 common shares, with 423,155 held directly and 1,882,967 controlled indirectly, as per the recent SEC filing." datetime: "2026-05-19T07:28:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286872009.md) - [en](https://longbridge.com/en/news/286872009.md) - [zh-HK](https://longbridge.com/zh-HK/news/286872009.md) --- # Zenas BioPharma Insider Bought Shares Worth $1,012,800, According to a Recent SEC Filing 03:28 AM EDT, 05/19/2026 (MT Newswires) -- Leon O Moulder Jr, Director, Chief Executive Officer, on May 18, 2026, executed a purchase for 60,000 shares in Zenas BioPharma ( ZBIO ) for $1,012,800. Following the Form 4 filing with the SEC, Moulder has control over a total of 2,306,122 common shares of the company, with 423,155 shares held directly and 1,882,967 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1953926/000110465926063362/xslF345X05/tm2615027-1\_4seq1.xml MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### Related Stocks - [ZBIO.US](https://longbridge.com/en/quote/ZBIO.US.md) ## Related News & Research - [How Zenas BioPharma’s First-in-Human Oral IL-17 Trial Could Reframe Zenas BioPharma (ZBIO) Investors](https://longbridge.com/en/news/286517927.md) - [Tomas Kiselak resigns from Zenas BioPharma board after term expiration](https://longbridge.com/en/news/286241504.md) - [Zenas BioPharma To Present INDIGO Phase 3 Data At EULAR 2026; Wedbush Sees $45 Target](https://longbridge.com/en/news/286916856.md) - [Tuesday 5/19 Insider Buying Report: ZBIO, ICFI](https://longbridge.com/en/news/286954937.md) - [Zenas BioPharma Highlights Strong Q1 Progress and Financing](https://longbridge.com/en/news/286243392.md)